⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ONCY News
Oncolytics Biotech, Inc. Common Shares
Form 8-K
sec.gov
ONCY
Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study
globenewswire.com
ONCY
Form 8-K
sec.gov
ONCY
Form 8-K
sec.gov
ONCY
Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer
globenewswire.com
ONCY
Form 8-K
sec.gov
ONCY
Oncolytics Biotech® Completes Domicile Change to the United States
globenewswire.com
ONCY
Form 8-K
sec.gov
ONCY
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
globenewswire.com
ATOS
ONCY
SNSE
TNGX
OSTX
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care
prnewswire.com
DAWN
TCRX
ENGN
ONCY
GILD